Health
Study: Anti-microRNA drug significantly reduces miR-92a levels in human peripheral blood – News-Medical.Net
A single intravenous dose of MRG-110, an anti-microRNA drug, significantly reduced miR-92a levels in the blood of healthy humans.
A single intravenous dose of MRG-110, an anti-microRNA drug, significantly reduced miR-92a levels in the blood of healthy humans.
Inhibition of miR-92a has shown beneficial effects in animal models, including improved vascularization after myocardial infarction, and accelerated wound healing, according to the peer-reviewed journal Nucleic Acid Therapeutics.
“Based on documented, promising therapeutic potential, locked nucleic acid (LNA)-based anti-miR-92a was further developed and tested in a …
-
General22 hours agoPolice investigating after body found on road in Newborough, Gippsland
-
General12 hours agoMan dies in daylight shooting in Sydney’s north-west
-
Noosa News21 hours agoCouncil steps up staff protection after surge in abuse
-
Business14 hours agoOrd Minnett names 2 ASX 200 shares to buy